Sygnature Discovery

Sygnature Discovery

About Sygnature Discovery

Simplify's Rating
Why Sygnature Discovery is rated
B-
Rated D+ on Competitive Edge
Rated A on Growth Potential
Rated B on Rating Differentiation

Industries

Biotechnology

Healthcare

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

United Kingdom

Founded

2004

Overview

Company Does Not Provide H1B Sponsorship

Simplify Jobs

Simplify's Take

What believers are saying

  • The EcoVadis award aligns with increasing demand for sustainability in life sciences.
  • Collaboration with Axol Bioscience could attract clients interested in innovative research.
  • Expansion into North America suggests potential for increased market share and opportunities.

What critics are saying

  • Over-reliance on Elsevier could pose risks if the partnership faces challenges.
  • New leadership may lead to strategic shifts disrupting current operations.
  • Focus on sustainability may require resources impacting other operational areas.

What makes Sygnature Discovery unique

  • Sygnature Discovery's EcoVadis Bronze award highlights its commitment to sustainable practices.
  • The partnership with Axol Bioscience positions Sygnature at the forefront of drug discovery.
  • New leadership appointments bring extensive pharma and biotech experience to Sygnature Discovery.

Help us improve and share your feedback! Did you find this helpful?

Company News

Sygnature Discovery
Oct 9th, 2024
Sygnature Discovery has Chosen Elsevier as New Preferred Partner to Empower its Global Team of Chemists

Sygnature Discovery has chosen Elsevier as new preferred partner to empower its global team of chemists.

Contract Pharma
Oct 3rd, 2024
Sygnature Discovery Names Amira Modi as COO

Contract research organization (CRO) Sygnature Discovery has appointed Amira Modi as its new Chief Operating Officer (COO) and Board member.

Sygnature Discovery
Aug 20th, 2024
Sygnature Discovery boosts North American growth with new General Manager

World-leading contract research organization Sygnature Discovery has announced a major new addition to its leadership team, with the high-profile appointment of industry veteran Jade Dagher as General Manager, Canada.

PharmiWeb
May 1st, 2024
Sygnature Discovery Receives Ecovadis Award For Sustainable Excellence

World-leading contract research organisation Sygnature Discovery has announced its Bronze rating from EcoVadis, in recognition of the company’s commitment to sustainable practices in the life sciences sector.EcoVadis, a globally respected sustainability ratings platform, evaluates companies across various industries on environmental, social, and ethical performance criteria.Sygnature Discovery has implemented a range of sustainable initiatives over a three-year period including reducing carbon emissions in laboratory practices, recycling palladium waste, reducing the number of ultra-low temperature freezers, transitioning to paperless invoicing, and recycling IT equipment.Additionally, a dedicated environmental committee meets monthly to discuss and implement sustainable practices and is represented by non-scientific and scientific employee groups including the Green Chemistry and BioScience groups.Sygnature has also demonstrated its commitment to environmental stewardship through its participation in this year’s International Laboratory Freezer Challenge, organised by My Green Lab, in collaboration with the International Institute for Sustainable Laboratories (I2SL).The six-month freezer challenge prompts labs to implement efficient cold storage practices, submitting score sheets for the chance to win awards.Sygnature Discovery CEO Dr Simon Hirst commented: “As an industry leader, we have a responsibility to lead by example and set the standard for sustainable excellence and we recognise the importance of minimising our environmental footprint, promoting ethical conduct, and fostering social responsibility.“This year’s International Laboratory Freezer Challenge is just one element of that commitment. As part of our corporate strategy, we have embedded sustainability into every aspect of our operations so we can help create a healthier, more sustainable future for patients, communities, and the planet.“With over 125,000 companies rated globally, the EcoVadis Bronze award reflects our ongoing commitment to sustainability. The award places Sygnature Discovery in the top 35% of companies that EcoVadis has surveyed and we are very proud to be recognised for our efforts.”During the assessment process, EcoVadis takes four key themes into consideration, including how a company impacts the environment, labour and human rights, ethics and sustainable procurement. They use their findings to award medals based on performance.By achieving the EcoVadis Bronze award, Sygnature Discovery joins a select group of companies recognised for their commitment to sustainability in life sciences.EcoVadis sustainability ratings are grounded in international sustainability standards, including the Ten Principles of the UN Global Compact, International Labour Organization (ILO) conventions, Global Reporting Initiative (GRI) standards, and the ISO 26000 standard. The ratings not only provide an evidence-based analysis of performance, but also offer actionable recommendations for continuous improvement.[Ends]About Sygnature DiscoverySygnature Discovery is a world-leading integrated drug discovery contract research organisation based in the UK and Canada with headquarters in Nottingham (UK). Additional sites are located in Alderley Park, Macclesfield and Glasgow (UK), as well as Montreal and Quebec City (Canada)

Nutraceutical Business Review
May 1st, 2024
Sygnature Discovery receives Ecovadis award for sustainable excellence

Sygnature Discovery receives ecovadis award for sustainable excellence.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Sygnature Discovery right now.

Find jobs on Simplify and start your career today

💡
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →